Trial · NCT03252626
Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
NCT03252626, Phase 4, Unknown, The First Hospital of Jilin University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke. Trials, record NCT03252626. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03252626
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
- NCT number
- NCT03252626
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 950 participants, estimated
- Lead sponsor
- The First Hospital of Jilin University
- Conditions
- Stroke
- Interventions
- Alprostadil, Normal saline
- First posted
- 2017-08-17
- Last updated
- 2024-04-01
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Modified Rankin Scale at Day 90 | day 90 | |
| Secondary | Incidence of major vascular events in 30 or 90 days including ischemic stroke and hemorrhagic stroke | day 30, day 90 | Major adverse vascular events include ischemic stroke, hemorrhagic stroke, TIA, myocardial infarction and vascular-related death. |
| Secondary | Incidence of stroke events in 30 or 90 days including ischemic stroke and hemorrhagic stroke | day 30, day 90 | |
| Secondary | Barthel Index score | day 30, day 90 | compared the changes in activities of daily living (Barthel index) between the two groups |
| Secondary | EQ-5D scale | day 30, day 90 | compared the changes in EQ-5D scale |
| Secondary | Documentation of adverse events (AEs) | day 30, day 90 | compared the rates of adverse events |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03252626
GET https://conductscience.org/api/trials/v1/NCT03252626/registered